361 results on '"Beck-Broichsitter, Moritz"'
Search Results
2. Bioinspired zwitterionic triblock copolymers designed for colloidal drug delivery: 2 - Biological evaluation
3. Bioinspired zwitterionic triblock copolymers designed for colloidal drug delivery: 1 — Synthesis and characterization
4. Analytical techniques for the characterization of nanoparticles for mRNA delivery
5. In vitro degradation and erosion behavior of commercial PLGAs used for controlled drug delivery
6. Characterization of commercial PLGAs by NMR spectroscopy
7. Solvent impact on polymer nanoparticles prepared nanoprecipitation
8. Has PEG-PLGA advantages for the delivery of hydrophobic drugs? Risperidone as an example
9. Polymer-coated aperture plates for tailored atomization processes
10. Optimization of budesonide-loaded large-porous microparticles for inhalation using quality by design approach
11. Making Concentrated Antibody Formulations Accessible for Vibrating-Mesh Nebulization
12. Influence of solvent mixtures on HPMCAS-celecoxib microparticles prepared by electrospraying
13. Sustained therapeutic efficacy of budesonide-loaded chitosan swellable microparticles after lung delivery: Influence of in vitro release, treatment interval and dose
14. Correction to: Characterization of commercial PLGAs by NMR spectroscopy
15. Impact of triblock copolymers on the biophysical function of naturally-derived lung surfactant
16. Medication Tracking: Design and Fabrication of a Dry Powder Inhaler with Integrated Acoustic Element by 3D Printing
17. Potential of surface-eroding poly(ethylene carbonate) for drug delivery to macrophages
18. Stability-limit ⿿Ouzo region⿿ boundaries for poly(lactide-co-glycolide) nanoparticles prepared by nanoprecipitation
19. Influence of amine-modified poly(vinyl alcohol)s on vibrating-membrane nebulizer performance and lung toxicity
20. Potential of the isolated lung technique for the examination of sildenafil absorption from lung-delivered poly(lactide-co-glycolide) microparticles
21. Disintegration of nano-embedded microparticles after deposition on mucus: A mechanistic study
22. Prolonged vasodilatory response to nanoencapsulated sildenafil in pulmonary hypertension
23. Preparation of Nanoscale Pulmonary Drug Delivery Formulations by Spray Drying
24. Standardization and validation of a protocol of size measurements by dynamic light scattering for monodispersed stable nanomaterial characterization
25. Fabrication and characterization of hyaluronic acid microneedles to enhance delivery of magnesium ascorbyl phosphate into skin
26. Modified vibrating-mesh nozzles for advanced spray-drying applications
27. Biophysical inhibition of pulmonary surfactant function by polymeric nanoparticles: Role of surfactant protein B and C
28. Controlling the droplet size of formulations nebulized by vibrating-membrane technology
29. Nebulization of Active Pharmaceutical Ingredients with the eFlow®rapid: Impact of Formulation Variables on Aerodynamic Characteristics
30. Boosting the aerodynamic properties of vibrating-mesh nebulized polymeric nanosuspensions
31. In vitro degradation and erosion behavior of commercial PLGAs used for controlled drug delivery
32. In situ forming parenteral depot systems based on poly(ethylene carbonate): Effect of polymer molecular weight on model protein release
33. Enzyme-responsive surface erosion of poly(ethylene carbonate) for controlled drug release
34. Insulin-like growth factor-I aerosol formulations for pulmonary delivery
35. In situ forming nimodipine depot system based on microparticles for the treatment of posthemorrhagic cerebral vasospasm
36. Correlation of drug release with pulmonary drug absorption profiles for nebulizable liposomal formulations
37. Electrolyte type and nozzle composition affect the process of vibrating-membrane nebulization
38. Impact of lyoprotectants for the stabilization of biodegradable nanoparticles on the performance of air-jet, ultrasonic, and vibrating-mesh nebulizers
39. Controlled pulmonary drug and gene delivery using polymeric nano-carriers
40. Optimising the self-assembly of siRNA loaded PEG-PCL-lPEI nano-carriers employing different preparation techniques
41. Characterization of novel spray-dried polymeric particles for controlled pulmonary drug delivery
42. Development of a biodegradable nanoparticle platform for sildenafil: Formulation optimization by factorial design analysis combined with application of charge-modified branched polyesters
43. Self-assembled biodegradable amphiphilic PEG–PCL–lPEI triblock copolymers at the borderline between micelles and nanoparticles designed for drug and gene delivery
44. Biophysical investigation of pulmonary surfactant surface properties upon contact with polymeric nanoparticles in vitro
45. Preparation of nanoparticles by solvent displacement for drug delivery: A shift in the “ouzo region” upon drug loading
46. Correction to: Characterization of commercial PLGAs by NMR spectroscopy
47. Design attributes of long-circulating polymeric drug delivery vehicles
48. Characterization of lung-delivered in-situ forming controlled release formulations
49. Following the Concentration of Polymeric Nanoparticles During Nebulization
50. Polymer Nanoparticle-Based Controlled Pulmonary Drug Delivery
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.